HDM Sublingual Immunotherapy Tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HDM Sublingual Immunotherapy Tablet, covering 2025-06-10 to 2025-06-10. Get the full timeline:
Most recent: Clinical Trial Update: Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab [Phase 3]